Should you buy AURA stock?
Last updated:
Based on market data through , StockInvest.us rates Aura Biosciences, Inc. (AURA) as Hold/Accumulate with a technical score of -0.77 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation.
- Hold signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Down 11.69%
- Easy Tracking In The Watchlist
Aura Biosciences, Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session
(Market data through Aug 04, 2026)
The Aura Biosciences, Inc. stock price gained 1.56% on the last trading day (Tuesday, 4th Aug 2026), rising from $7.04 to $7.15. During the last trading day the stock fluctuated 2.41% from a day low at $7.06 to a day high of $7.23. The price has been going up and down for this period, and there has been a 1.71% gain for the last 2 weeks. Volume fell on the last day by -171 thousand shares and in total, 251 thousand shares were bought and sold for approximately $1.79 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $7.39 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -11.69% during the next 3 months and, with a 90% probability hold a price between $4.89 and $6.53 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
AURA Signals & Forecast
The Aura Biosciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.08 and $6.96. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -7.62%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Aura Biosciences, Inc. stock
Aura Biosciences, Inc. finds support from accumulated volume at $7.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.170 between high and low, or 2.41%. For the last week the stock has had daily average volatility of 3.54%.
Our recommended stop-loss: $6.88 (-3.72%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 22 days ago.)
Trading Expectations (AURA) For The Upcoming Trading Day Of Wednesday 5th
For the upcoming trading day on Wednesday, 5th we expect Aura Biosciences, Inc. to open at $7.15, and during the day (based on 14 day Average True Range), to move between $6.99 and $7.31, which gives a possible trading interval of +/-$0.322 (+/-4.60%) up or down from last closing price. If Aura Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 4.60% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $7.01 (1.96%) than the resistance at $7.47 (4.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Aura Biosciences, Inc. will release earnings BMO on Wednesday, August 12, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.410. We will update the financials statements for Aura Biosciences, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.95% in the first trading day after earnings release.
Is Aura Biosciences, Inc. stock A Buy?
Aura Biosciences, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
-0.774
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 5, 2026 - $7.15 ( 0.0466%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AURA Performance
Trading levels for AURA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.32 | 2.33% |
| R2 | 7.25 | 1.42% |
| R1 | 7.21 | 0.86% |
| Price | 7.15 | |
| S1 | 7.08 | -0.95% |
| S2 | 7.04 | -1.52% |
| S3 | 6.98 | -2.42% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.90 | 24.48% |
| R2 | 7.74 | 8.25% |
| R1 | 7.47 | 4.48% |
| Price | 7.15 | |
| S1 | 7.01 | -1.96% |
| S2 | 7.00 | -2.10% |
| S3 | 6.34 | -11.33% |
FAQ
Click here for our free guide on how to buy Aura Biosciences, Inc. Stock.
Buy AURA